Mary Caffrey

Prior Authorization Panel Yields Insights Into Role of PBMs in Biosimilar Uptake

March 09, 2022

At a session at the Association of Community Cancer Centers’ 2022 Annual Meeting & Cancer Center Business Summit, panelists suggested that the quest for rebates by pharmacy benefit managers (PBMs) prevents uptake on some biosimilars—and could soon bleed over into biosimilar formulary placement.

Biosimilars CEOs: Opportunities Abound, but Regulatory, “Branding” Hurdles Remain

February 24, 2022

There remains risk in the US market due to regulatory and legal hurdles—not to mention a combative political environment, according to executives who gathered last week during the “CEOs Unplugged” session at Access! 2022, held by the Association for Accessible Medicines (AAM) in Orlando.

CMS Seeks Answers for Slower-Than-Expected Biosimilar Adoption, Rawal Says

February 21, 2022

Purva Rawal, PhD, senior advisor and chief strategy officer, Center for Medicare and Medicaid Innovation, spoke during the Association for Accessible Medicines' Access! annual meeting, which gathered in Orlando, Florida, February 15-16.

In Iceland, Switch to Adalimumab Biosimilar Reveals Issues With Injection Device

February 15, 2022

Iceland’s national health plan required patients to switch from Humira to the Samsung Bioepis biosimilar, Imraldi, which had a different injection device and contained citrate, a chemical buffer used to maintain the medication’s stability.

Cardinal Health Report Sees 2022 as “Turning Point” for Biosimilars

February 08, 2022

The year 2022 “is set to be a turning point” in the United States, as biosimilars are on their way to delivering $133 billion in aggregate savings by 2025, according to Cardinal Health's “2022 Biosimilars Report: The U.S. Journey and Path Ahead.”

Amid Good Signs on Biosimilars, COVID-19 Upends Drug Purchasing Patterns

April 20, 2020

Douglas M. Long, MBA, vice president of Industry Relations for IQVIA, surveyed COVID-19's effects on the pharmaceutical marketplace as he kicked off AMCP eLearning Days, a webinar series held in place of the annual meeting of the Academy of Managed Care Pharmacy (AMCP).